Anesthetic Isoflurane Posttreatment Attenuates Experimental Lung Injury by Inhibiting Inflammation and Apoptosis
We investigated the effect of 1.4% isoflurane (ISO) on the development of inflammation and apoptosis caused by zymosan (ZY) in mice. We found that ZY-challenged mice exhibited significant body weight loss, markedly high mortality, and significant lung injury characterized by the deterioration of his...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c38d42b3b4774dbfa5211e7de10373f5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Jun-tang Li |e author |
700 | 1 | 0 | |a Hui Wang |e author |
700 | 1 | 0 | |a Wei Li |e author |
700 | 1 | 0 | |a Li-feng Wang |e author |
700 | 1 | 0 | |a Li-chao Hou |e author |
700 | 1 | 0 | |a Jing-lan Mu |e author |
700 | 1 | 0 | |a Xin Liu |e author |
700 | 1 | 0 | |a Hui-juan Chen |e author |
700 | 1 | 0 | |a Ke-lang Xie |e author |
700 | 1 | 0 | |a Nan-lin Li |e author |
700 | 1 | 0 | |a Chun-fang Gao |e author |
245 | 0 | 0 | |a Anesthetic Isoflurane Posttreatment Attenuates Experimental Lung Injury by Inhibiting Inflammation and Apoptosis |
260 | |b Hindawi Limited, |c 2013-01-01T00:00:00Z. | ||
500 | |a 0962-9351 | ||
500 | |a 1466-1861 | ||
500 | |a 10.1155/2013/108928 | ||
520 | |a We investigated the effect of 1.4% isoflurane (ISO) on the development of inflammation and apoptosis caused by zymosan (ZY) in mice. We found that ZY-challenged mice exhibited significant body weight loss, markedly high mortality, and significant lung injury characterized by the deterioration of histopathology, histologic scores, and wet-to-dry ratio after ISO treatment. ISO dramatically attenuated ZY-induced lung neutrophil recruitment and inflammation, as evidenced by the reduced levels of total cells, neutrophils, and proinflammatory cytokines (i.e., tumor necrosis factor-α, interleukin- (IL-) 1β, IL-6, and macrophage inflammatory protein-2) in bronchoalveolar lavage fluid and of their mRNA expression in lung tissues. ISO also inhibited ZY-induced expression and activation of nuclear factor-kappaB p65 and inducible nitric oxide synthase in pulmonary tissue. ZY administration also resulted in the upregulation of heme oxygenase-1 expression and activity in the lung, which was further enhanced by ISO treatment. Moreover, ISO markedly prevented ZY-induced pulmonary cell apoptosis in mice, as reflected by the decrease in expression of procaspase-8, procaspase-3, cleaved caspase-8, and cleaved caspase-3, as well as in caspase-3 activity and Bcl-2-associated X/B-cell lymphoma 2 ratio. These results indicate that ISO is a potential therapeutic drug for treating ZY-induced lung injury, and further investigations are warranted. | ||
546 | |a EN | ||
690 | |a Pathology | ||
690 | |a RB1-214 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Mediators of Inflammation, Vol 2013 (2013) | |
787 | 0 | |n http://dx.doi.org/10.1155/2013/108928 | |
787 | 0 | |n https://doaj.org/toc/0962-9351 | |
787 | 0 | |n https://doaj.org/toc/1466-1861 | |
856 | 4 | 1 | |u https://doaj.org/article/c38d42b3b4774dbfa5211e7de10373f5 |z Connect to this object online. |